Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhen'ao Honeysuckle Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and health products derived from honeysuckle (Lonicera japonica). Based in Dalian, the company operates as a key subsidiary of the Zhen-Ao Group, leveraging advanced extraction technologies to produce high-purity botanical extracts. Its product portfolio primarily focuses on anti-inflammatory and antiviral treatments for respiratory conditions and general wellness. The company maintains GMP-certified manufacturing facilities and integrates modern biotechnology with traditional herbal medicine. Zhen'ao Honeysuckle Pharmaceutical plays a significant role in the Chinese domestic market for natural antiviral and anti-inflammatory remedies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhen'ao Honeysuckle Pharmaceutical.